Paediatrics – Suspected Childhood Cancer (2WW) New Pathway

Published: 10th March 2022
During this free webinar, speakers from the CCLG, West Midlands Cancer Alliance and clinicians in the Coventry and Warwickshire area, share insight into implementing the new Paediatric 2WW pathway via Consultant Connect, key learnings to date and future plans.

Following the Children’s Cancer and Leukaemia Group (CCLG) new referral guidelines for suspected cancer in children and young people in April 2021, University Hospitals Coventry and Warwickshire NHS Trust (UHCW) launched a new Paediatric 2WW pathway via Consultant Connect, in November 2021.

During this free webinar, speakers from the CCLG, West Midlands Cancer Alliance and clinicians in the Coventry and Warwickshire area, share insight into implementing the new Paediatric 2WW pathway via Consultant Connect, key learnings to date and future plans.

Webinar speakers:

  • Ashley Ball-Gamble: CEO, CCLG
  • Dr Kim Neuling: Lead Clinician Paediatric Oncology, UHCW
  • Dr Hazel Blanchard: GP Partner at Forrest Medical Centre
  • Dr Dave Hobin: West Midlands Cancer Alliance

Webinar Chair:

  • Lucy Sammons, COO, Consultant Connect

Agenda:

  • Introductions and context setting: New CCLG Guidelines
  • Implementation: How Consultant Connect and UHCW worked in partnership to implement the new pathway
  • Learnings: Stats to date, Primary Care and Lead Clinician Paediatric Oncology experience
  • Q&A 

Related links:

 

If you have any questions about the webinar or how we can support your area, please do not hesitate to contact us on 01865 261467 or email info@consultantconnect.org.uk.

Share this

Contact us

For more information about how we work with commissioners, hospitals & mental health trusts to improve patient care, please get in touch.

Join a webinar

Listen to health experts from the comfort of your desk as we bring the experts to you in our series of online webinars.

Join our mailing list

Join our mailing list and we'll keep you informed of our latest blogs, project news, and upcoming webinar dates and topics.

0
0